Skip to main content
xMedica

Search

50 studies match these filters. Showing 26–50 of 50 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT04889872PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 80 sites in total

RecruitingNot applicable2,250target80 / 62021Dec 17, 2025
NCT06455787J-Valve Transfemoral Pivotal Study

The primary objective of this study is to assess the safety and efficacy of the J-Valve Transfemoral (TF) System in patients with symptomatic, severe (grade 3 or 4), native aortic valve regurgitation (AR) and AR-dominant mixed aortic valve disease, who are judged by a multi-disciplinary heart team t…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 40 sites in total · contact listed

RecruitingNot applicable194target40 / 52024May 4, 2026
NCT04634240Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise re…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 72 sites in total · contact listed

RecruitingNot applicable4,000target72 / 22020Jul 24, 2025
NCT05701358Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardia…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 113 sites in total · contact listed

RecruitingNot applicable5,100target113 / 172023Jun 19, 2025
NCT06378632AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 45 sites in total · contact listed

Recruiting500target45 / 32022Mar 26, 2025
NCT05102019Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardial ischemia in the distribution of the left coro…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 96 sites in total

RecruitingNot applicable380target96 / 32022Aug 26, 2026
NCT06297291Global Paradise System US Post Approval Study

The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 43 sites in total · contact listed

Recruiting1,000target43 / 12024Aug 12, 2026
NCT07069673Abbott Cephea Mitral Valve Disease Registry

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of cor…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 24 sites in total · contact listed

Recruiting1,000target24 / 12025Sep 10, 2026
NCT05677100Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejec…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 50 sites in total

RecruitingNot applicable320target50 / 22023Aug 25, 2026
NCT07064473EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 1,143 sites in total · contact listed

RecruitingPhase 311,800target1,143 / 512025Sep 16, 2026
NCT07037459Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fract…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 657 sites in total

RecruitingPhase 35,056target657 / 342025Sep 16, 2026
NCT07610278A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

This is a multicenter, randomized, double-blind, factorial design Phase 2 study to evaluate the pharmacodynamics, safety and tolerability of a combination of QCZ484 and inclisiran compared to QCZ484, inclisiran, and placebo in participants with hypertension and concomitant hypercholesterolemia.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 29 sites in total · contact listed

RecruitingPhase 2120target29 / 12026Jul 30, 2026
NCT07567001A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to fi…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 838 sites in total

RecruitingPhase 35,610target838 / 272026Aug 18, 2026
NCT05065216Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limit…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 86 sites in total · contact listed

RecruitingPhase 2 / Phase 3728target86 / 102021Sep 14, 2026
NCT06307652Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapag…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 852 sites in total

RecruitingPhase 33,850target852 / 392024Sep 11, 2026
NCT06990867Optimizing Reperfusion to Improve Outcomes and Neurologic Function

The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 83 sites in total · contact listed

RecruitingPhase 2 / Phase 3740target83 / 182025Mar 13, 2026
NCT06742723A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure

Contact Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 771 sites in total

RecruitingPhase 35,000target771 / 422025Aug 26, 2026
NCT05485961Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo. Part 2: Phase 3 aims to assess the efficacy of CSL300 vs placebo on cardiovascular (CV) out…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 557 sites in total · contact listed

RecruitingPhase 2 / Phase 33,110target557 / 352022Aug 11, 2026
NCT06531824EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). Pe…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 557 sites in total · contact listed

RecruitingPhase 311,000target557 / 202024Sep 17, 2026
NCT07662213A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 209 sites in total

RecruitingPhase 31,200target209 / 152026Sep 9, 2026
NCT07213778REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 36 sites in total

RecruitingPhase 32,000target36 / 42025Sep 14, 2026
NCT07764978Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

This is a randomised, multicentre, controlled, open-label, Phase III global study comparing the efficacy and safety of standard induction regimens (IsaVRd and DRd) followed by AZD0120 versus standard induction regimens followed by continuous therapy (IsaRd and DRd) in participants with newly diagnos…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 124 sites in total

RecruitingPhase 3750target124 / 152026Aug 14, 2026
NCT07654361Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calor…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed

RecruitingPhase 33,600target71 / 12026Aug 10, 2026
NCT04566328Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell g…

Contact Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 647 sites in total

RecruitingPhase 31,450target647 / 22021Aug 19, 2026
NCT07546929HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to cel…

Contact Claimed

Nearest site: El Dorado, Kansas, United States — 85 km away · 25 sites in total · contact listed

RecruitingPhase 2300target25 / 12023Apr 23, 2026

Filters

Clear all filters